Search - tctmd.com

Displaying 601 - 620 of 788

Sort: Relevancy | Date

News Conference News TCT 2012

Large Study Finds Comparable 8-Month TVF for PES, SES

October 23, 2012

$Mobilized CD 34+ Cells for Refractory Angina$

Presentation TCT 2012

Mobilized CD 34+ Cells for Refractory Angina

Presenter: Thomas Povsic

October 22, 2012

News Conference News TCT 2012

COURAGE, FAME: Revascularization More Effective Than OMT

October 22, 2012

News Daily News

Un Informe del Registro CathPCI Detalla los Patrones Contemporáneos de Práctica Clínica en EE.UU.

Caitlin E. Cox

October 18, 2012

News Daily News

CathPCI Registry Report Details Contemporary US Practice Patterns

Caitlin E. Cox

October 18, 2012

News Daily News

Subestudio FAME: La PCI guiada por FFR es igual para Mujeres y Hombres

October 17, 2012

News Daily News

FAME Substudy: FFR-Guided PCI Just as Beneficial for Women as Men

October 17, 2012

News Industry News

Revascularization with OrbusNeich’s Genous™ Stent May Enable the Safe and Early Discontinuation of Dual Antiplatelet Therapy for Patients with Increased Bleeding Risk

October 12, 2012

News Daily News

Un Meta análisis estudia Nuevos Anticoagulantes + Terapia Doble en Pacientes que han sufrido un SCA

October 02, 2012

News Daily News

Stent Fractures Persist Among Newer-Generation Devices

Jason Kahn

October 02, 2012

News Daily News

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

October 02, 2012

News Daily News

Las Fracturas del Stent Persisten en los Dispositivos de Nueva Generación

Jason Kahn

October 02, 2012

News Industry News

Boston Scientific Launches Emerge™ PTCA Balloon Dilatation Catheter in the U.S.

September 27, 2012

News Daily News

Un Estudio Plantea Dudas sobre la Necesidad de Realizar Más Pruebas tras Cuadros Resueltos de Dolor Torácico

L.A. McKeown

September 24, 2012

News Daily News

Paper Raises Doubts About Need for Further Testing After Resolved Chest Pain

L.A. McKeown

September 24, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

News Daily News

Door-to-Activation Shows Most Impact on D2B Times in STEMI Patients

September 14, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Caitlin E. Cox

August 29, 2012

Advertisement

Large Study Finds Comparable 8-Month TVF for PES, SES

Mobilized CD 34+ Cells for Refractory Angina

COURAGE, FAME: Revascularization More Effective Than OMT

Un Informe del Registro CathPCI Detalla los Patrones Contemporáneos de Práctica Clínica en EE.UU.

CathPCI Registry Report Details Contemporary US Practice Patterns

Subestudio FAME: La PCI guiada por FFR es igual para Mujeres y Hombres

FAME Substudy: FFR-Guided PCI Just as Beneficial for Women as Men

Revascularization with OrbusNeich’s Genous™ Stent May Enable the Safe and Early Discontinuation of Dual Antiplatelet Therapy for Patients with Increased Bleeding Risk

Un Meta análisis estudia Nuevos Anticoagulantes + Terapia Doble en Pacientes que han sufrido un SCA

Stent Fractures Persist Among Newer-Generation Devices

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

Las Fracturas del Stent Persisten en los Dispositivos de Nueva Generación

Boston Scientific Launches Emerge™ PTCA Balloon Dilatation Catheter in the U.S.

Un Estudio Plantea Dudas sobre la Necesidad de Realizar Más Pruebas tras Cuadros Resueltos de Dolor Torácico

Paper Raises Doubts About Need for Further Testing After Resolved Chest Pain

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

Door-to-Activation Shows Most Impact on D2B Times in STEMI Patients

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content